Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Cash from Operations (2022 - 2023)

Vycor Medical (VYCO) has disclosed Cash from Operations for 6 consecutive years, with 5508.0 as the latest value for Q4 2023.

  • Quarterly Cash from Operations rose 116.51% to 5508.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was 29430.0 through Dec 2023, up 113.56% year-over-year, with the annual reading at 13471.0 for FY2025, 122.41% down from the prior year.
  • Cash from Operations for Q4 2023 was 5508.0 at Vycor Medical, up from 14863.0 in the prior quarter.
  • The five-year high for Cash from Operations was 24621.0 in Q1 2023, with the low at 78780.0 in Q1 2022.